<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Flat White

Why should we rely on mRNA vaccines?

9 July 2021

4:00 AM

9 July 2021

4:00 AM

Last month the federal government announced that the AstraZeneca vaccine would be phased out, with it being available only ‘on request’ after October of this year. This decision followed numerous blood clotting cases and some deaths occurring following vaccination.  

The government will now rely on the Pfizer and Moderna vaccines. However, these mRNA inoculations are not without their problems, either.

Already a subscriber? Log in

Easter flash sale:
10 issues for $1

Subscribe this Easter and get the next 10 issues of the magazine, plus website and app access, all for just $1.

  • Weekly delivery of the magazine
  • Unlimited access to spectator.com.au and app
  • Spectator Australia podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock 3 articles a month

REGISTER


Comments

Easter flash sale: 10 issues for $1

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close